Gujarat FDCA Forms Special Flying Squads To Combat Sale Of Adulterated, Counterfeit & Spurious Medicines

Mumbai: In a groundbreaking initiative to tackle the sale of adulterated, counterfeit, and spurious medicines, the Gujarat Food and Drug Control Administration (FDCA) has formed special flying squads for the first time in the state’s history. These squads, comprising two enforcement teams each, are led by an assistant commissioner and include senior drug inspectors and drug inspectors. This strategic move has been approved by the state government to enhance surveillance and monitoring across the pharmaceutical supply chain.

Dr HG Koshia, the FDCA Commissioner, hailed the formation of these squads as a “landmark move” in ensuring the safety and efficacy of medicines available in the market. “In order to curb the clandestine activity involving the sale of adulterated, counterfeit, and spurious medicines, Gujarat FDCA has set up a special flying squad of two enforcement teams each headed by an assistant commissioner and comprising senior drug inspectors and drug inspectors for the first time in Gujarat for effective surveillance and monitoring,” stated Dr. Koshia.

The enforcement teams have been meticulously selected from a pool of 175 officers within the Gujarat FDCA’s enforcement department, based on their competence and track record. These squads are tasked with monitoring the entire supply chain, which includes over 6,000 manufacturers and around 55,000 wholesalers and retailers across Gujarat.

The primary objective of these squads is to conduct regular and surprise inspections, ensure compliance with drug safety regulations, and take stringent actions against violators. By doing so, the FDCA aims to safeguard public health and maintain the integrity of the pharmaceutical market.

Dr. Koshia emphasized the importance of this initiative, stating, “The formation of these squads marks a significant step towards ensuring that only safe and genuine medicines reach the consumers. We are committed to maintaining the highest standards of drug safety and will take all necessary measures to eliminate any threats posed by adulterated and counterfeit drugs.”

Related Posts

  • Pharma
  • April 28, 2025
  • 97 views
Gujrat leads pharma sector with record 183 new plants

Ahmedabad:  Gujarat has further cemented its position as India’s pharmaceutical powerhouse with the state’s Food and Drug Control Administration (FDCA) approving 183 new allopathic drug manufacturing facilities in FY 2024-25,…

  • Pharma
  • April 28, 2025
  • 107 views
Doctor not liable for prescribing costly drug: HC

Cuttack:  Orissa high court has ruled that a doctor should not be held criminally liable for prescribing a particular drug of any pharmaceutical company for treatment of a disease like…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gujrat leads pharma sector with record 183 new plants

Gujrat leads pharma sector with record 183 new plants

Doctor not liable for prescribing costly drug: HC

Doctor not liable for prescribing costly drug: HC

878 Tramadol capsules being smuggled in Scorpio seized, three arrested

878 Tramadol capsules being smuggled in Scorpio seized, three arrested

Doctor not criminally liable for prescribing costly drug: Orissa High Court

Doctor not criminally liable for prescribing costly drug: Orissa High Court

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion